MiaMed
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Developer of brain disorder medicines. The company provides research and development services for cyclin-dependent kinase-like 5 focused on treatment of brain disorders.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- 641 Lexington Avenue
- 15th Floor
- New York, NY 10022
- United States
MiaMed Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore MiaMed‘s full profile, request access.
Request full access to PitchBook